Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
News & Media
  • Press Releases
  • Presentations
  • Events
  • Publications
  • Training Videos

Press Releases

Nov 26, 2014

Aethlon Medical Announces First Hemopurifier® Shipment To Support the Treatment of Ebola in the United States

Nov 25, 2014

Ebola Patient Who Received Aethlon Hemopurifier® Therapy Has Been Discharged From Hospital

Nov 21, 2014

Time Magazine Names The Aethlon Hemopurifier® One of the 25 Best Inventions of 2014

Nov 19, 2014

Aethlon Medical Discloses Expanded Access "Emergency Use" Pathway To Treat Ebola in the United States

Nov 14, 2014

Aethlon Medical's Hemopurifier® Used in Successful Treatment of Patient with Advanced Ebola Infection

Nov 11, 2014

Aethlon Medical to Present at Tomorrow's SeeThruEquity Conference

Nov 10, 2014

Aethlon Medical Announces Presentation of Ebola Treatment Data This Friday, November 14th at the ASN Annual Meeting

Nov 6, 2014

Aethlon Medical Announces Undetectable Ebola Virus in Patient Treated with Hemopurifier® Therapy

Oct 29, 2014

Aethlon Medical Discloses Ebola Treatment Pathways in the United States

Oct 14, 2014

Aethlon Medical Announces First Treatment of an Ebola Patient

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.